The Oncolytic Virus Therapy market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

ALSO READ : http://www.marketwatch.com/story/oncolytic-virus-therapy-market-res...

Market segmentation

Oncolytic Virus Therapy market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers

HSV-based Oncolytic Viruses

Adenoviruses-based Oncolytic Viruses

Vaccinia Virus-based Oncolytic Viruses

Vesicular Stomatitis Virus-based Oncolytic Viruses

Newcastle Disease Virus-based Oncolytic Viruses

Market segment by Application, can be divided into

Melanoma

Prostate Cancer

ALSO READ :http://www.marketwatch.com/story/automotive-acoustic-engineering-ma...

Breast Cancer

Ovarian Cancer

Others

Market segment by players, this report covers

Amgen

Oncolytics Biotech

Viralytics

Transgene SA

Oncolys BioPharma

Targovax

PsiOxus Therapeutics

SillaJen Biotherapeutics

Sorrento Therapeutics

Lokon Pharma

Genelux Corporation

Vyriad

TILT Biotherapeutics

Cold Genesys

Market segment by regions, regional analysis covers

North America (United States, Canada, and Mexico)

Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)

South America (Brazil, Argentina, Rest of South America)

Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 12 chapters:

Chapter 1, to describe Oncolytic Virus Therapy product scope, market overview, market opportunities, market driving force and market risks.

ALSO READ :http://www.marketwatch.com/story/robotic-bartender-market-research-...

Chapter 2, to profile the top players of Oncolytic Virus Therapy, with revenue, gross margin and global market share of Oncolytic Virus Therapy from 2019 to 2021.

Chapter 3, the Oncolytic Virus Therapy competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.

Chapter 4 and 5, to segment the market size by type and application, with revenue and growth rate by type, application, from 2016 to 2026.

Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2016 to 2021.and Oncolytic Virus Therapy market forecast, by regions, type and application, with revenue, from 2021 to 2026.

Chapter 11 and 12, to describe Oncolytic Virus Therapy research findings and conclusion, appendix and data source.

ALSO READ : http://www.marketwatch.com/story/alumina-crucibles-market-research-...

Table of Contents

1 Market Overview

1.1 Product Overview and Scope of Oncolytic Virus Therapy

1.2 Classification of Oncolytic Virus Therapy by Type

1.2.1 Overview: Global Oncolytic Virus Therapy Market Size by Type: 2020 Versus 2021 Versus 2026

1.2.2 Global Oncolytic Virus Therapy Revenue Market Share by Type in 2020

1.2.3 HSV-based Oncolytic Viruses

1.2.4 Adenoviruses-based Oncolytic Viruses

1.2.5 Vaccinia Virus-based Oncolytic Viruses

1.2.6 Vesicular Stomatitis Virus-based Oncolytic Viruses

1.2.7 Newcastle Disease Virus-based Oncolytic Viruses

1.3 Global Oncolytic Virus Therapy Market by Application

1.3.1 Overview: Global Oncolytic Virus Therapy Market Size by Application: 2020 Versus 2021 Versus 2026

1.3.2 Melanoma

1.3.3 Prostate Cancer

1.3.4 Breast Cancer

1.3.5 Ovarian Cancer

1.3.6 Others

1.4 Global Oncolytic Virus Therapy Market Size & Forecast

1.5 Global Oncolytic Virus Therapy Market Size and Forecast by Region

1.5.1 Global Oncolytic Virus Therapy Market Size by Region: 2016 VS 2021 VS 2026

1.5.2 Global Oncolytic Virus Therapy Market Size by Region, (2016-2021)

1.5.3 North America Oncolytic Virus Therapy Market Size and Prospect (2016-2026)

1.5.4 Europe Oncolytic Virus Therapy Market Size and Prospect (2016-2026)

1.5.5 Asia-Pacific Oncolytic Virus Therapy Market Size and Prospect (2016-2026)

1.5.6 South America Oncolytic Virus Therapy Market Size and Prospect (2016-2026)

1.5.7 Middle East and Africa Oncolytic Virus Therapy Market Size and Prospect (2016-2026)

1.6 Market Drivers, Restraints and Trends

1.6.1 Oncolytic Virus Therapy Market Drivers

1.6.2 Oncolytic Virus Therapy Market Restraints

1.6.3 Oncolytic Virus Therapy Trends Analysis

2 Company Profiles

2.1 Amgen

2.1.1 Amgen Details

2.1.2 Amgen Major Business

2.1.3 Amgen Oncolytic Virus Therapy Product and Solutions

2.1.4 Amgen Oncolytic Virus Therapy Revenue, Gross Margin and Market Share (2019-2021)

2.1.5 Amgen Recent Developments and Future Plans

2.2 Oncolytics Biotech

2.2.1 Oncolytics Biotech Details

2.2.2 Oncolytics Biotech Major Business

2.2.3 Oncolytics Biotech Oncolytic Virus Therapy Product and Solutions

2.2.4 Oncolytics Biotech Oncolytic Virus Therapy Revenue, Gross Margin and Market Share (2019-2021)

2.2.5 Oncolytics Biotech Recent Developments and Future Plans

2.3 Viralytics

2.3.1 Viralytics Details

2.3.2 Viralytics Major Business

2.3.3 Viralytics Oncolytic Virus Therapy Product and Solutions

2.3.4 Viralytics Oncolytic Virus Therapy Revenue, Gross Margin and Market Share (2019-2021)

2.3.5 Viralytics Recent Developments and Future Plans

2.4 Transgene SA

2.4.1 Transgene SA Details

2.4.2 Transgene SA Major Business

2.4.3 Transgene SA Oncolytic Virus Therapy Product and Solutions

2.4.4 Transgene SA Oncolytic Virus Therapy Revenue, Gross Margin and Market Share (2019-2021)

2.4.5 Transgene SA Recent Developments and Future Plans

2.5 Oncolys BioPharma

2.5.1 Oncolys BioPharma Details

2.5.2 Oncolys BioPharma Major Business

2.5.3 Oncolys BioPharma Oncolytic Virus Therapy Product and Solutions

2.5.4 Oncolys BioPharma Oncolytic Virus Therapy Revenue, Gross Margin and Market Share (2019-2021)

2.5.5 Oncolys BioPharma Recent Developments and Future Plans

2.6 Targovax

2.6.1 Targovax Details

2.6.2 Targovax Major Business

2.6.3 Targovax Oncolytic Virus Therapy Product and Solutions

2.6.4 Targovax Oncolytic Virus Therapy Revenue, Gross Margin and Market Share (2019-2021)

2.6.5 Targovax Recent Developments and Future Plans

2.7 PsiOxus Therapeutics

2.7.1 PsiOxus Therapeutics Details

2.7.2 PsiOxus Therapeutics Major Business

2.7.3 PsiOxus Therapeutics Oncolytic Virus Therapy Product and Solutions

2.7.4 PsiOxus Therapeutics Oncolytic Virus Therapy Revenue, Gross Margin and Market Share (2019-2021)

2.7.5 PsiOxus Therapeutics Recent Developments and Future Plans

2.8 SillaJen Biotherapeutics

2.8.1 SillaJen Biotherapeutics Details

2.8.2 SillaJen Biotherapeutics Major Business

2.8.3 SillaJen Biotherapeutics Oncolytic Virus Therapy Product and Solutions

2.8.4 SillaJen Biotherapeutics Oncolytic Virus Therapy Revenue, Gross Margin and Market Share (2019-2021)

2.8.5 SillaJen Biotherapeutics Recent Developments and Future Plans

2.9 Sorrento Therapeutics

2.9.1 Sorrento Therapeutics Details

2.9.2 Sorrento Therapeutics Major Business

2.9.3 Sorrento Therapeutics Oncolytic Virus Therapy Product and Solutions

2.9.4 Sorrento Therapeutics Oncolytic Virus Therapy Revenue, Gross Margin and Market Share (2019-2021)

2.9.5 Sorrento Therapeutics Recent Developments and Future Plans

2.10 Lokon Pharma

2.10.1 Lokon Pharma Details

2.10.2 Lokon Pharma Major Business

2.10.3 Lokon Pharma Oncolytic Virus Therapy Product and Solutions

2.10.4 Lokon Pharma Oncolytic Virus Therapy Revenue, Gross Margin and Market Share (2019-2021)

2.10.5 Lokon Pharma Recent Developments and Future Plans

2.11 Genelux Corporation

2.11.1 Genelux Corporation Details

2.11.2 Genelux Corporation Major Business

2.11.3 Genelux Corporation Oncolytic Virus Therapy Product and Solutions

2.11.4 Genelux Corporation Oncolytic Virus Therapy Revenue, Gross Margin and Market Share (2019-2021)

2.11.5 Genelux Corporation Recent Developments and Future Plans

2.12 Vyriad

2.12.1 Vyriad Details

2.12.2 Vyriad Major Business

2.12.3 Vyriad Oncolytic Virus Therapy Product and Solutions

2.12.4 Vyriad Oncolytic Virus Therapy Revenue, Gross Margin and Market Share (2019-2021)

2.12.5 Vyriad Recent Developments and Future Plans

2.13 TILT Biotherapeutics

2.13.1 TILT Biotherapeutics Details

2.13.2 TILT Biotherapeutics Major Business

2.13.3 TILT Biotherapeutics Oncolytic Virus Therapy Product and Solutions

2.13.4 TILT Biotherapeutics Oncolytic Virus Therapy Revenue, Gross Margin and Market Share (2019-2021)

2.13.5 TILT Biotherapeutics Recent Developments and Future Plans

2.14 Cold Genesys

2.14.1 Cold Genesys Details

2.14.2 Cold Genesys Major Business

2.14.3 Cold Genesys Oncolytic Virus Therapy Product and Solutions

2.14.4 Cold Genesys Oncolytic Virus Therapy Revenue, Gross Margin and Market Share (2019-2021)

2.14.5 Cold Genesys Recent Developments and Future Plans

3 Market Competition, by Players

ALSO READ : http://www.marketwatch.com/story/car-networking-system-market-resea...

3.1 Global Oncolytic Virus Therapy Revenue and Share by Players (2019-2021)

3.2 Market Concentration Rate

3.2.1 Top 3 Oncolytic Virus Therapy Players Market Share

3.2.2 Top 10 Oncolytic Virus Therapy Players Market Share

3.2.3 Market Competition Trend

3.3 Oncolytic Virus Therapy Players Head Office, Products and Services Provided

3.4 Mergers & Acquisitions

3.5 New Entrants and Expansion Plans

4 Market Size Segment by Type

4.1 Global Oncolytic Virus Therapy Revenue and Market Share by Type (2016-2021)

4.2 Global Oncolytic Virus Therapy Market Forecast by Type (2021-2026)

5 Market Size Segment by Application

5.1 Global Oncolytic Virus Therapy Revenue Market Share by Application (2016-2021)

5.2 Oncolytic Virus Therapy Market Forecast by Application (2021-2026)

6 North America by Country, by Type, and by Application

6.1 North America Oncolytic Virus Therapy Revenue by Type (2016-2026)

6.2 North America Oncolytic Virus Therapy Revenue by Application (2016-2026)

6.3 North America Oncolytic Virus Therapy Market Size by Country

6.3.1 North America Oncolytic Virus Therapy Revenue by Country (2016-2026)

6.3.2 United States Oncolytic Virus Therapy Market Size and Forecast (2016-2026)

6.3.3 Canada Oncolytic Virus Therapy Market Size and Forecast (2016-2026)

6.3.4 Mexico Oncolytic Virus Therapy Market Size and Forecast (2016-2026)

7 Europe by Country, by Type, and by Application

7.1 Europe Oncolytic Virus Therapy Revenue by Type (2016-2026)

7.2 Europe Oncolytic Virus Therapy Revenue by Application (2016-2026)

7.3 Europe Oncolytic Virus Therapy Market Size by Country

7.3.1 Europe Oncolytic Virus Therapy Revenue by Country (2016-2026)

7.3.2 Germany Oncolytic Virus Therapy Market Size and Forecast (2016-2026)

7.3.3 France Oncolytic Virus Therapy Market Size and Forecast (2016-2026)

7.3.4 United Kingdom Oncolytic Virus Therapy Market Size and Forecast (2016-2026)

7.3.5 Russia Oncolytic Virus Therapy Market Size and Forecast (2016-2026)

7.3.6 Italy Oncolytic Virus Therapy Market Size and Forecast (2016-2026)

8 Asia-Pacific by Region, by Type, and by Application

8.1 Asia-Pacific Oncolytic Virus Therapy Revenue by Type (2016-2026)

8.2 Asia-Pacific Oncolytic Virus Therapy Revenue by Application (2016-2026)

8.3 Asia-Pacific Oncolytic Virus Therapy Market Size by Region

8.3.1 Asia-Pacific Oncolytic Virus Therapy Revenue by Region (2016-2026)

8.3.2 China Oncolytic Virus Therapy Market Size and Forecast (2016-2026)

8.3.3 Japan Oncolytic Virus Therapy Market Size and Forecast (2016-2026)

8.3.4 South Korea Oncolytic Virus Therapy Market Size and Forecast (2016-2026)

8.3.5 India Oncolytic Virus Therapy Market Size and Forecast (2016-2026)

8.3.6 Southeast Asia Oncolytic Virus Therapy Market Size and Forecast (2016-2026)

8.3.7 Australia Oncolytic Virus Therapy Market Size and Forecast (2016-2026)

9 South America by Country, by Type, and by Application

9.1 South America Oncolytic Virus Therapy Revenue by Type (2016-2026)

9.2 South America Oncolytic Virus Therapy Revenue by Application (2016-2026)

9.3 South America Oncolytic Virus Therapy Market Size by Country

9.3.1 South America Oncolytic Virus Therapy Revenue by Country (2016-2026)

9.3.2 Brazil Oncolytic Virus Therapy Market Size and Forecast (2016-2026)

9.3.3 Argentina Oncolytic Virus Therapy Market Size and Forecast (2016-2026)

10 Middle East & Africa by Country, by Type, and by Application

10.1 Middle East & Africa Oncolytic Virus Therapy Revenue by Type (2016-2026)

10.2 Middle East & Africa Oncolytic Virus Therapy Revenue by Application (2016-2026)

10.3 Middle East & Africa Oncolytic Virus Therapy Market Size by Country

10.3.1 Middle East & Africa Oncolytic Virus Therapy Revenue by Country (2016-2026)

10.3.2 Turkey Oncolytic Virus Therapy Market Size and Forecast (2016-2026)

10.3.3 Saudi Arabia Oncolytic Virus Therapy Market Size and Forecast (2016-2026)

10.3.4 UAE Oncolytic Virus Therapy Market Size and Forecast (2016-2026)

11 Research Findings and Conclusion

12 Appendix

12.1 Methodology

12.2 Research Process and Data Source

12.3 Disclaimer

List of Tables

Table 1. Global Oncolytic Virus Therapy Revenue by Type, (USD Million), 2020 VS 2021 VS 2026

Table 2. Global Oncolytic Virus Therapy Revenue by Application, (USD Million), 2020 VS 2021 VS 2026

Table 3. Global Market Oncolytic Virus Therapy Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)

Table 4. Global Oncolytic Virus Therapy Revenue (USD Million) by Region (2016-2021)

Table 5. Global Oncolytic Virus Therapy Revenue Market Share by Region (2021-2026)

Table 6. Amgen Corporate Information, Head Office, and Major Competitors

Table 7. Amgen Major Business

…continued

CONTACT DETAILS :

[email protected]

+44 203 500 2763

+1 62 825 80070

971 0503084105